Launch of the Medical Psychedelics Working Group

On Tuesday July 14th, 2020, Drug Science will launch a new working group of experts, policy makers and scientists. Its primary role is to campaign for the rescheduling of all psychedelic drugs for research and medical purposes. However, current UK regulations have created serious and considerable barriers to legitimate research associated with Schedule 1 regulations.  …

Cannabis Review for the attention of the WHO

Click me: Success - 30/11/2016 The scheduling under the Single Convention on Narcotic Drugs assumes a scientific justification. However, cannabis and cannabis resin have never been evaluated by the World Health Organisation (WHO) since it was mandated the review of psychoactive substances in 1948. The last evaluation for the international substance control conventions were therefore  …